| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lo Andrew | Director | C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO | /s/ Andrew Lo | 06 May 2025 | 0001679076 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BBIO | Common Stock | Sale | $3,849,900 | -100,000 | -49% | $38.50 | 105,583 | 02 May 2025 | By Andrew W. Lo and Nancy N. Lo JTWROS | F1 |
| holding | BBIO | Common Stock | 48,099 | 02 May 2025 | Direct |
| Id | Content |
|---|---|
| F1 | Represents the weighted average sale price of the shares sold from $38.155 to $38.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |